Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
American Journal of Clinical Oncology|March 2, 2011
Pathologic response to short intensified taxane-free neoadjuvant chemotherapy in patients with highly proliferative operable breast cancerChristophe Le Tourneau, Sarah Dettwiler, Philippe Beuzeboc, et al.
International Journal of Cancer|September 10, 2005
Antigen-independent accumulation of activated effector/memory T lymphocytes into human and murine tumorsNathalie T Joncker, Marie-Annick Marloie, Anna Chernysheva, et al.
Technology in Cancer Research & Treatment|September 5, 2013
Large field, high resolution full-field optical coherence tomography: a pre-clinical study of human breast tissue and cancer assessmentOsnath Assayag, Martine Antoine, Brigitte Sigal-Zafrani, et al.
Clinical & Experimental Metastasis|November 8, 2008
Time to metastatic relapse and breast cancer cells dissemination in bone marrow at metastatic relapseFrançois-Clément Bidard, Anne Vincent-Salomon, Brigitte Sigal-Zafrani, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2010
Improving the definition of tumor bed boost with the use of surgical clips and image registration in breast cancer patientsYoulia M Kirova, Pablo Castro Pena, Tarek Hijal, et al.
Breast Cancer Research and Treatment|March 23, 2012
The fibroblast growth factor receptor 1 (FGFR1), a marker of response to chemoradiotherapy in breast cancer?Carole Massabeau, Brigitte Sigal-Zafrani, Lisa Belin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 31, 2007
Responses to concurrent radiotherapy and hormone-therapy and outcome for large breast cancers in post-menopausal womenMarc A Bollet, Youlia M Kirova, Guillemette Antoni, et al.
European Journal of Cancer (Oxford, England : 1990)|August 9, 2006
Pathological response to preoperative concurrent chemo-radiotherapy for breast cancer: results of a phase II studyMarc A Bollet, Brigitte Sigal-Zafrani, Laetitia Gambotti, et al.
Breast Cancer Research and Treatment|May 19, 2010
A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patientsJean-Yves Pierga, Suzette Delaloge, Marc Espié, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapseFrancois-Clément Bidard, Anne Vincent-Salomon, Stéphanie Gomme, et al.
Pageof 8